Sanofi SA header image

Sanofi SA

SNY

Equity

ISIN null / Valor 1447201

NASDAQ (2026-07-02)
USD 43.16+3.68%

Sanofi SA
UMushroom community rating:

star star star star star
4.00 2 votes No rating yet
NegativeNeutralPositive

About company

Sanofi SA is a Paris-headquartered, publicly traded multinational pharmaceutical company that researches, develops, manufactures and commercializes prescription medicines, vaccines and consumer health products for global markets. Its business spans vaccines (Sanofi Pasteur) and a pharmaceuticals portfolio focused on areas such as immunology, rare diseases, oncology, diabetes and cardiovascular care, with a mix of small-molecule and biologic medicines; the company also markets over‑the‑counter and consumer healthcare products. Sanofi generates revenue from product sales and partnerships with other biopharma firms, supports an active R&D pipeline across therapeutic areas, and operates global manufacturing and distribution networks to supply markets worldwide.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-12.5%1Y
-19.9%3Y
-17.6%5Y

Performance

26.8%1Y
62.1%3Y
50.3%5Y

Volatility

Market cap

104235 M

Market cap (USD)

Daily traded volume (Shares)

3,459,475

Daily traded volume (Shares)

1 day high/low

48.65 / 48.21

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

2 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
3.50
Society:
starstarstarstarstar
3.50
Nature:
starstarstarstarstar
3.50
Milena Klasing Chen
Switzerland, 30 Mar 2025
star star star star star
Stable
Milena Klasing Chen
Switzerland, 24 Mar 2025
star star star star star
Ok

EQUITIES OF THE SAME SECTOR

Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc Ultragenyx Pharmaceutical Inc Valor: 22860122
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.37%USD 33.47
Pacira BioSciences Inc
Pacira BioSciences Inc Pacira BioSciences Inc Valor: 12338490
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.44%USD 25.39
Boston Scientific Corp
Boston Scientific Corp Boston Scientific Corp Valor: 913577
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.83%USD 45.14
Medtronic PLC
Medtronic PLC Medtronic PLC Valor: 25187155
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.04%USD 83.19
Teladoc Health Inc
Teladoc Health Inc Teladoc Health Inc Valor: 28438140
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.10%USD 9.20
Rhythm Pharmaceuticals Inc
Rhythm Pharmaceuticals Inc Rhythm Pharmaceuticals Inc Valor: 25337263
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.41%USD 114.17
Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc Amphastar Pharmaceuticals Inc Valor: 24511852
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.29%USD 19.64
The Platform Group AG
The Platform Group AG The Platform Group AG Valor: 57796644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.69%EUR 0.96
Unitedhealth Group Inc
Unitedhealth Group Inc Unitedhealth Group Inc Valor: 1078451
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.28%USD 425.36
Encompass Health Corporation
Encompass Health Corporation Encompass Health Corporation Valor: 39085960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.00%USD 106.46